🔥🐔 BizChicken 🐔🔥
Companies Similar to Ocuphire Pharma, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Aytu BioPharma, Inc.
Adzenys XR-ODT
Aytu Biopharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics and consumer healthcare products in the United States and internationally. They offer products for the treatment of ADHD, allergies, fluoride deficiency, cough, and insomnia.
Symbol: AYTU
Recent Price: $1.61
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Joshua R. Disbrow
Sector: Healthcare
Employees: 102
Address: 373 Inverness Parkway, Englewood, CO 80112
Phone: 720 437 6580
Last updated: 2024-12-31
Eyenovia, Inc.
Optejet
Eyenovia, Inc. is focused on developing therapeutic solutions for ophthalmic conditions using its proprietary microdose array print platform and Optejet delivery system. It targets conditions like progressive myopia, presbyopia, and mydriasis.
Symbol: EYEN
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. Michael M. Rowe
Sector: Healthcare
Employees: 57
Address: 295 Madison Avenue, New York, NY 10017
Phone: 917 289 1117
Leadership
- Charles Mather, Chairman of the Board
- Ellen Strahlman, MD, MS, Independent Director
- Sean Ianchulev, MD, MPH, Director
- Michael Geltzeiler, Independent Director
- Rachel Jacobson, Independent Director
- Ram Palanki, PharmD, Independent Director
- Michael Rowe, Director
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Amylyx Pharmaceuticals, Inc.
AMX0035
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Their leading product, AMX0035, is aimed at ALS treatment.
About | Leadership | Directors | Contact | Careers | About | About | About | About | About | About | About | About | News | About
Symbol: AMLX
Recent Price: $3.84
Industry: Biotechnology
CEO: Mr. Joshua B. Cohen
Sector: Healthcare
Employees: 384
Address: 43 Thorndike Street, Cambridge, MA 02141
Phone: 617 682 0917
Leadership
- Linda A. Arsenault, Chief Human Resources Officer
- Camille L. Bedrosian, MD, Chief Medical Officer
- Josh Cohen, Co-CEO & Co-Founder
- James M. Frates, Chief Financial Officer
- Tom Holmes, Chief Technical Operations Officer
- Justin Klee, Co-CEO & Co-Founder
- Gina M. Mazzariello, Chief Legal Officer & General Counsel
- Rudolph Tanzi, PhD, Founding Chair of the Amylyx SAB
- Wally Gilbert, Special Advisor
- Kari Firestone, Director
- Paul Fonteyne, Director
- George Milne, Chairman
- Daphne Quimi, Director
- Bernhardt G. Zeiher, MD, FACP, FCCP, Director
Last updated: 2024-12-31
Cumberland Pharmaceuticals Inc.
Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.
Symbol: CPIX
Recent Price: $2.42
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. A. J. Kazimi MBA
Sector: Healthcare
Employees: 91
Address: 2525 West End Avenue, Nashville, TN 37203
Phone: 615 255 0068
Last updated: 2024-12-31
EyePoint Pharmaceuticals, Inc.
ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50
Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.
About | Contact | Contact | ESG | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: EYPT
Recent Price: $7.02
Industry: Biotechnology
CEO: Dr. Jay S. Duker M.D.
Sector: Healthcare
Employees: 121
Address: 480 Pleasant Street, Watertown, MA 02472
Phone: 617 926 5000
Last updated: 2024-12-31
Harrow Health, Inc.
Imprimis Rx, DEXYCU
Harrow Health, Inc. is an ophthalmic-focused healthcare company owning several pharmaceutical businesses and equity interests in clinical-stage companies, dedicated to innovative treatments in eye health and anesthesia.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | About
Symbol: HROW
Recent Price: $33.38
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark L. Baum J.D.
Sector: Healthcare
Employees: 315
Address: 102 Woodmont Boulevard, Nashville, TN 37205
Phone: 615 733 4730
Last updated: 2024-12-31
IRIDEX Corporation
Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems
IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.
About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: IRIX
Recent Price: $1.74
Industry: Medical - Devices
CEO: Mr. Patrick Mercer
Sector: Healthcare
Employees: 111
Address: 1212 Terra Bella Avenue, Mountain View, CA 94043
Phone: 650 940 4700
Last updated: 2024-12-31
Kala Pharmaceuticals, Inc.
KPI-012, EYSUVIS, INVELTYS
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.
Contact | Careers | Jobs | Careers | Careers | Careers | Careers | Leadership | Careers | Contact | Careers | Careers | Careers | About
Symbol: KALA
Recent Price: $6.87
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark T. Iwicki
Sector: Healthcare
Employees: 43
Address: 1167 Massachusetts Avenue, Arlington, MA 02476
Phone: 781 996 5252
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Ocugen, Inc.
OCU400, OCU410, OCU200
Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases. Its product pipeline includes gene therapy candidates targeting various retinal diseases and other conditions.
Symbol: OCGN
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shankar Musunuri M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 263 Great Valley Parkway, Malvern, PA 19355
Phone: 484 328 4701
Last updated: 2024-12-31
Ocuphire Pharma, Inc.
Nyxol
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.
Symbol: OCUP
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. George Magrath M.B.A., M.D., M.S.
Sector: Healthcare
Employees: 14
Address: 37000 Grand River Avenue, Farmington Hills, MI 48335
Phone: 248 681 9815
Last updated: 2024-12-31
Ovid Therapeutics Inc.
OV101, OV329, OV350, OV882, OV815
Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.
Our Story | Leadership | Directors | About | Our Story | Contact | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | About | Culture | Culture | About | Jobs | Careers | Careers | Jobs | About | About | About | Careers | Vision/Values | About | About | About | About | About | About
Symbol: OVID
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Sector: Healthcare
Employees: 40
Address: 1460 Broadway, New York, NY 10036
Phone: 646 661 7661
Leadership
- Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
- Meg Alexander, President and Chief Operating Officer
- Zhong Zhong, Ph.D., Chief Scientific Officer
- Jeffrey Rona, Chief Business and Financial Officer
- Amanda Banks, M.D., Chief Development Officer
- Julia Tsai, Ph.D., Senior Vice President of Clinical Development
- Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
- Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
- Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
- Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
- Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Trevena, Inc.
OLINVYK (Oliceridine) injection
Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.
Symbol: TRVN
Recent Price: $1.50
Industry: Biotechnology
CEO: Ms. Carrie L. Bourdow
Sector: Healthcare
Employees: 23
Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087
Phone: 610 354 8840
Leadership
- Carrie L. Bourdow, President and Chief Executive Officer
- Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
- Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
- Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
- Scott Braunstein, M.D., Lead Independent Director
- Dr. Mark Corrigan, Acting CEO
- Marvin H. Johnson, Jr., Board Member
- Jake R. Nunn, Board Member
- Anne M. Phillips, M.D., Board Member
- Barbara Yanni, Board Member
Last updated: 2024-12-31
Cosmos Health Inc.
pharmaceuticals, nutraceuticals, medical devices
Cosmos Health Inc. is a vertically integrated pharmaceutical company offering branded and generic pharmaceuticals, medical devices, and more, serving wholesale distributors and retail pharmacies. Headquartered in Chicago, it has distribution centers in Greece and the UK.
Symbol: COSM
Recent Price: $0.67
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Grigorios Siokas
Sector: Healthcare
Employees: 123
Address: 141 West Jackson Boulevard, Chicago, IL 60604
Phone: 312 536 3102
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31